Multiple Lung Carcinoma (Non-small Cell Lung Carcinoma, NSCLC) And Normal Tissue Form Necroscopy Tissue Array, 70 Cases/208 Cores, With Stage And Grade Information|ヒト組織アレイ
掲載日情報:2015/08/07 現在Webページ番号:174250
US Biomax社は、豊富なラインナップの組織アレイ、組織切片(凍結、FFPE)を提供しているメーカーです。
US Biomax社のヒト組織アレイ(Multiple Lung Carcinoma (Non-small Cell Lung Carcinoma, NSCLC) And Normal Tissue Form Necroscopy Tissue Array, 70 Cases/208 Cores, With Stage And Grade Information)をご紹介します。
※ヒト組織アレイは、ドナーからインフォームドコンセントを取得した組織を使用しています。
※ドナーの組織は、HIV、Hepatitis B、Hepatitis Cが陰性であることを確認しています。
※本製品は研究用です。研究用以外には使用できません。
追加しました。
ヒト組織アレイの価格
[在庫・価格 :2024年05月16日 17時55分現在]
詳細 | 商品名 |
|
文献数 | ||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tissue array of multiple lung carcinoma and normal tissue form necroscopy tissue |
|
0 | |||||||||||||||||||||||||||||||||||||||||||||||||||
|
[在庫・価格 :2024年05月16日 17時55分現在]
Tissue array of multiple lung carcinoma and normal tissue form necroscopy tissue
文献数: 0
- 商品コード:LC2081
- メーカー:USB
- 包装:1slide
- 価格:¥114,000
- 在庫:無(未発注)
- 納期:2~3週間 ※※ 表示されている納期は弊社に在庫がなく、取り寄せた場合の目安納期となります。
- 法規制等:
説明文 | |||
---|---|---|---|
法規制等 | |||
保存条件 | 法規備考 | ||
掲載カタログ |
|
||
製品記事 |
TissueArray.Com社 組織アレイ(Tissue array) 選択ガイド |
||
関連記事 |
TissueArray.Com社 パラフィン組織スライド/組織アレイの仕様変更につきまして |
追加しました。
ヒト組織アレイの特長
Microarray Panel: | Multiple lung carcinoma and normal tissue microarray, triplicate cores per case, 24 cases of squamous cell carcinoma, 24 adenocarcinoma, 12 large cell carcinoma and 9 normal lung tissue from necroscopy. The last core is malignant melanoma of skin as tissue marker | |
---|---|---|
Cores: | 208 | |
Cases: | 70 | |
Layout: | 16 cols × 13 rows | |
Core Diameter: | 1 mm | |
Thickness: | 5 µm | |
Quality Control: | Anti-Actin confirmed | |
Applications: | Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page. |
|
Notes: | Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure. |
*Tissue Microarray Slide Types:
- Unstained: unstained paraffin tissue microarray slide.
- Trial: tissue microarray trial slide. 10% - 25% of cores missing. Good for titrating antibody dilution and experiment conditions. Limited numbers are available, to 2 per item per order. Test slides (tissue arrays with catalog numbers ending with 241 or 242) are recommended as a substitute.
- H and E: Hematoxylin and Eosin stained tissue array slide.
追加しました。
ヒト組織アレイの仕様表
Pos | No. | Sex | Age | Organ | Pathology diagnosis | Grade | Notes | Type † |
---|---|---|---|---|---|---|---|---|
A1 | 1 | M | 55 | Lung | Squamous cell carcinoma | 3 | T2N1M0 | Malignant |
A2 | 2 | M | 55 | Lung | Squamous cell carcinoma | 2 | T2N1M0 | Malignant |
A3 | 3 | M | 55 | Lung | Squamous cell carcinoma | 2 | T2N1M0 | Malignant |
A4 | 4 | M | 67 | Lung | Squamous cell carcinoma | 1 | T2NxM0 | Malignant |
A5 | 5 | M | 67 | Lung | Squamous cell carcinoma | 1 | T2NxM0 | Malignant |
A6 | 6 | M | 67 | Lung | Squamous cell carcinoma | 1 | T2NxM0 | Malignant |
A7 | 7 | M | 74 | Lung | Squamous cell carcinoma | 1 | T2NxM0 | Malignant |
A8 | 8 | M | 74 | Lung | Squamous cell carcinoma | 1 | T2NxM0 | Malignant |
A9 | 9 | M | 74 | Lung | Squamous cell carcinoma | 1 | T2NxM0 | Malignant |
A10 | 10 | M | 46 | Lung | Squamous cell carcinoma | 2 | T2N1M0 | Malignant |
A11 | 11 | M | 46 | Lung | Squamous cell carcinoma | 2 | T2N1M0 | Malignant |
A12 | 12 | M | 46 | Lung | Squamous cell carcinoma | 1 | T2N1M0 | Malignant |
A13 | 13 | F | 57 | Lung | Squamous cell carcinoma | 1 | T2NxM0 | Malignant |
A14 | 14 | F | 57 | Lung | Squamous cell carcinoma (chronic pneumonia) | – | T2NxM0 | Malignant |
A15 | 15 | F | 57 | Lung | Squamous cell carcinoma (chronic pneumonia) | – | T2NxM0 | Malignant |
A16 | 16 | M | 53 | Lung | Squamous cell carcinoma (lung tissue) | – | T3N0M0 | Malignant |
B1 | 17 | M | 53 | Lung | Squamous cell carcinoma (lung tissue) | – | T3N0M0 | Malignant |
B2 | 18 | M | 53 | Lung | Squamous cell carcinoma | 1 | T3N0M0 | Malignant |
B3 | 19 | M | 68 | Lung | Squamous cell carcinoma | 1 | T2N0M0 | Malignant |
B4 | 20 | M | 68 | Lung | Squamous cell carcinoma | 1 | T2N0M0 | Malignant |
B5 | 21 | M | 68 | Lung | Squamous cell carcinoma | 1 | T2N0M0 | Malignant |
B6 | 22 | M | 68 | Lung | Squamous cell carcinoma | 2 | T2N0M0 | Malignant |
B7 | 23 | M | 68 | Lung | Squamous cell carcinoma | 2 | T2N0M0 | Malignant |
B8 | 24 | M | 68 | Lung | Squamous cell carcinoma | 2 | T2N0M0 | Malignant |
B9 | 25 | F | 74 | Lung | Squamous cell carcinoma (pneumorrhagia) | – | T2N0M0 | Malignant |
B10 | 26 | F | 74 | Lung | Squamous cell carcinoma (mucoepidermoid carcinoma) | – | T2N0M0 | Malignant |
B11 | 27 | F | 74 | Lung | Squamous cell carcinoma (mucoepidermoid carcinoma) | – | T2N0M0 | Malignant |
B12 | 28 | M | 65 | Lung | Squamous cell carcinoma (adenosquamous carcinoma) | – | T2N0M0 | Malignant |
B13 | 29 | M | 65 | Lung | Squamous cell carcinoma (adenosquamous carcinoma) | – | T2N0M0 | Malignant |
B14 | 30 | M | 65 | Lung | Squamous cell carcinoma (adenosquamous carcinoma) | – | T2N0M0 | Malignant |
B15 | 31 | M | 72 | Lung | Squamous cell carcinoma | 1 | T3N0M0 | Malignant |
B16 | 32 | M | 72 | Lung | Squamous cell carcinoma | 1 | T3N0M0 | Malignant |
C1 | 33 | M | 72 | Lung | Squamous cell carcinoma | 2 | T3N0M0 | Malignant |
C2 | 34 | M | 53 | Lung | Squamous cell carcinoma | 3 | T3N1M0 | Malignant |
C3 | 35 | M | 53 | Lung | Squamous cell carcinoma | 3 | T3N1M0 | Malignant |
C4 | 36 | M | 53 | Lung | Squamous cell carcinoma | 3 | T3N1M0 | Malignant |
C5 | 37 | M | 69 | Lung | Squamous cell carcinoma | 3 | T2N3M0 | Malignant |
C6 | 38 | M | 69 | Lung | Squamous cell carcinoma | 3 | T2N3M0 | Malignant |
C7 | 39 | M | 69 | Lung | Squamous cell carcinoma | 3 | T2N3M0 | Malignant |
C8 | 40 | M | 70 | Lung | Squamous cell carcinoma | 2 | T2N1M0 | Malignant |
C9 | 41 | M | 70 | Lung | Squamous cell carcinoma | 1 | T2N1M0 | Malignant |
C10 | 42 | M | 70 | Lung | Squamous cell carcinoma (fibrous and blood vessel tissue) | – | T2N1M0 | Malignant |
C11 | 43 | M | 64 | Lung | Squamous cell carcinoma (undifferentiated carcinoma) | – | T3N2M0 | Malignant |
C12 | 44 | M | 64 | Lung | Squamous cell carcinoma (undifferentiated carcinoma) | – | T3N2M0 | Malignant |
C13 | 45 | M | 64 | Lung | Squamous cell carcinoma (undifferentiated carcinoma) | – | T3N2M0 | Malignant |
C14 | 46 | M | 66 | Lung | Squamous cell carcinoma | 2 | T2N1M0 | Malignant |
C15 | 47 | M | 66 | Lung | Squamous cell carcinoma | 2 | T2N1M0 | Malignant |
C16 | 48 | M | 66 | Lung | Squamous cell carcinoma | 2 | T2N1M0 | Malignant |
D1 | 49 | M | 43 | Lung | Squamous cell carcinoma | 3 | T3N0M0 | Malignant |
D2 | 50 | M | 43 | Lung | Squamous cell carcinoma | 3 | T3N0M0 | Malignant |
D3 | 51 | M | 43 | Lung | Squamous cell carcinoma | 3 | T3N0M0 | Malignant |
D4 | 52 | M | 57 | Lung | Squamous cell carcinoma | 3 | T3N0M0 | Malignant |
D5 | 53 | M | 57 | Lung | Squamous cell carcinoma | 3 | T3N0M0 | Malignant |
D6 | 54 | M | 57 | Lung | Squamous cell carcinoma | 3 | T3N0M0 | Malignant |
D7 | 55 | M | 61 | Lung | Squamous cell carcinoma | 3 | T3N0M0 | Malignant |
D8 | 56 | M | 61 | Lung | Squamous cell carcinoma | 3 | T3N0M0 | Malignant |
D9 | 57 | M | 61 | Lung | Squamous cell carcinoma | 3 | T3N0M0 | Malignant |
D10 | 58 | M | 68 | Lung | Squamous cell carcinoma | 3 | T4N0M0 | Malignant |
D11 | 59 | M | 68 | Lung | Squamous cell carcinoma | 3 | T4N0M0 | Malignant |
D12 | 60 | M | 68 | Lung | Squamous cell carcinoma | 3 | T4N0M0 | Malignant |
D13 | 61 | M | 63 | Lung | Squamous cell carcinoma | 3 | T3N2M1 | Malignant |
D14 | 62 | M | 63 | Lung | Squamous cell carcinoma | 3 | T3N2M1 | Malignant |
D15 | 63 | M | 63 | Lung | Squamous cell carcinoma | 3 | T3N2M1 | Malignant |
D16 | 64 | M | 63 | Lung | Squamous cell carcinoma | 3 | T2N0M0 | Malignant |
E1 | 65 | M | 63 | Lung | Squamous cell carcinoma | 3 | T2N0M0 | Malignant |
E2 | 66 | M | 63 | Lung | Squamous cell carcinoma | 3 | T2N0M0 | Malignant |
E3 | 67 | M | 45 | Lung | Squamous cell carcinoma (sparse) | 3 | T2N0M0 | Malignant |
E4 | 68 | M | 45 | Lung | Squamous cell carcinoma | 2 | T2N0M0 | Malignant |
E5 | 69 | M | 45 | Lung | Squamous cell carcinoma (sparse) | 3 | T2N0M0 | Malignant |
E6 | 70 | M | 47 | Lung | Squamous cell carcinoma | 3 | T1N0M0 | Malignant |
E7 | 71 | M | 47 | Lung | Squamous cell carcinoma | 3 | T1N0M0 | Malignant |
E8 | 72 | M | 47 | Lung | Squamous cell carcinoma | 3 | T1N0M0 | Malignant |
E9 | 73 | M | 73 | Lung | Adenocarcinoma | 1 | T2N0M0 | Malignant |
E10 | 74 | M | 73 | Lung | Adenocarcinoma | 3 | T2N0M0 | Malignant |
E11 | 75 | M | 73 | Lung | Adenocarcinoma | 1 | T2N0M0 | Malignant |
E12 | 76 | M | 60 | Lung | Adenocarcinoma (sparse) | 3 | T2N0M0 | Malignant |
E13 | 77 | M | 60 | Lung | Adenocarcinoma (sparse) | 3 | T2N0M0 | Malignant |
E14 | 78 | M | 60 | Lung | Adenocarcinoma | 1 | T2N0M0 | Malignant |
E15 | 79 | F | 53 | Lung | Adenocarcinoma | 1 | T2N1M0 | Malignant |
E16 | 80 | F | 53 | Lung | Adenocarcinoma | 1 | T2N1M0 | Malignant |
F1 | 81 | F | 53 | Lung | Adenocarcinoma | 1 | T2N1M0 | Malignant |
F2 | 82 | M | 41 | Lung | Adenocarcinoma | 2 | T2N0M0 | Malignant |
F3 | 83 | M | 41 | Lung | Adenocarcinoma | 1 | T2N0M0 | Malignant |
F4 | 84 | M | 41 | Lung | Adenocarcinoma | 1 | T2N0M0 | Malignant |
F5 | 85 | M | 70 | Lung | Adenocarcinoma | 1 | T1N0M0 | Malignant |
F6 | 86 | M | 70 | Lung | Adenocarcinoma | 1 | T1N0M0 | Malignant |
F7 | 87 | M | 70 | Lung | Adenocarcinoma | 1 | T1N0M0 | Malignant |
F8 | 88 | F | 48 | Lung | Adenocarcinoma (chronic pneumonia with atypia hyperplasia of bronchic epithelium) | – | T2N0M0 | Malignant |
F9 | 89 | F | 48 | Lung | Adenocarcinoma | 1 | T2N0M0 | Malignant |
F10 | 90 | F | 48 | Lung | Adenocarcinoma (sparse) | 3 | T2N0M0 | Malignant |
F11 | 91 | F | 64 | Lung | Adenocarcinoma (mucous alveolar cell carcinoma) | – | T2N1M0 | Malignant |
F12 | 92 | F | 64 | Lung | Adenocarcinoma (mucous alveolar cell carcinoma) | – | T2N1M0 | Malignant |
F13 | 93 | F | 64 | Lung | Adenocarcinoma (mucous alveolar cell carcinoma) | – | T2N1M0 | Malignant |
F14 | 94 | F | 69 | Lung | Adenocarcinoma | 2 | T1N0M0 | Malignant |
F15 | 95 | F | 69 | Lung | Adenocarcinoma | 2 | T1N0M0 | Malignant |
F16 | 96 | F | 69 | Lung | Adenocarcinoma | 2 | T1N0M0 | Malignant |
G1 | 97 | M | 68 | Lung | Adenocarcinoma | 2 | T2N1M1 | Malignant |
G2 | 98 | M | 68 | Lung | Adenocarcinoma | 2 | T2N1M1 | Malignant |
G3 | 99 | M | 68 | Lung | Adenocarcinoma | 2 | T2N1M1 | Malignant |
G4 | 100 | F | 52 | Lung | Adenocarcinoma | 2 | T3N1M0 | Malignant |
G5 | 101 | F | 52 | Lung | Adenocarcinoma | 2 | T3N1M0 | Malignant |
G6 | 102 | F | 52 | Lung | Adenocarcinoma | 2 | T3N1M0 | Malignant |
G7 | 103 | M | 62 | Lung | Adenocarcinoma | 2 | T2N2M0 | Malignant |
G8 | 104 | M | 62 | Lung | Adenocarcinoma | 1 | T2N2M0 | Malignant |
G9 | 105 | M | 62 | Lung | Adenocarcinoma | 2 | T2N2M0 | Malignant |
G10 | 106 | M | 42 | Lung | Adenocarcinoma | 1 | T2N2M0 | Malignant |
G11 | 107 | M | 42 | Lung | Adenocarcinoma | 1 | T2N2M0 | Malignant |
G12 | 108 | M | 42 | Lung | Adenocarcinoma | 1 | T2N2M0 | Malignant |
G13 | 109 | M | 46 | Lung | Adenocarcinoma | 2 | T2N2M0 | Malignant |
G14 | 110 | M | 46 | Lung | Adenocarcinoma | 3 | T2N2M0 | Malignant |
G15 | 111 | M | 46 | Lung | Adenocarcinoma | 2 | T2N2M0 | Malignant |
G16 | 112 | M | 77 | Lung | Adenocarcinoma | 2 | T3N0M0 | Malignant |
H1 | 113 | M | 77 | Lung | Adenocarcinoma | 2 | T3N0M0 | Malignant |
H2 | 114 | M | 77 | Lung | Adenocarcinoma | 2 | T3N0M0 | Malignant |
H3 | 115 | F | 46 | Lung | Adenocarcinoma | 3 | T2N0M0 | Malignant |
H4 | 116 | F | 46 | Lung | Adenocarcinoma | 2 | T2N0M0 | Malignant |
H5 | 117 | F | 46 | Lung | Adenocarcinoma | 2 | T2N0M0 | Malignant |
H6 | 118 | M | 68 | Lung | Adenocarcinoma | 2 | T2N2M0 | Malignant |
H7 | 119 | M | 68 | Lung | Adenocarcinoma | 2 | T2N2M0 | Malignant |
H8 | 120 | M | 68 | Lung | Adenocarcinoma | 2 | T2N2M0 | Malignant |
H9 | 121 | F | 54 | Lung | Adenocarcinoma | 3 | T2NxM0 | Malignant |
H10 | 122 | F | 54 | Lung | Adenocarcinoma | 3 | T2NxM0 | Malignant |
H11 | 123 | F | 54 | Lung | Adenocarcinoma | 2 | T2NxM0 | Malignant |
H12 | 124 | M | 76 | Lung | Adenocarcinoma | 3 | T2N1M0 | Malignant |
H13 | 125 | M | 76 | Lung | Adenocarcinoma | 3 | T2N1M0 | Malignant |
H14 | 126 | M | 76 | Lung | Adenocarcinoma | 3 | T2N1M0 | Malignant |
H15 | 127 | M | 53 | Lung | Adenocarcinoma | 3 | T3N0M0 | Malignant |
H16 | 128 | M | 53 | Lung | Adenocarcinoma | 3 | T3N0M0 | Malignant |
I1 | 129 | M | 53 | Lung | Adenocarcinoma | 3 | T3N0M0 | Malignant |
I2 | 130 | F | 54 | Lung | Adenocarcinoma | 3 | T3N1M0 | Malignant |
I3 | 131 | F | 54 | Lung | Adenocarcinoma | 3 | T3N1M0 | Malignant |
I4 | 132 | F | 54 | Lung | Adenocarcinoma | 3 | T3N1M0 | Malignant |
I5 | 133 | M | 67 | Lung | Adenocarcinoma | 3 | T2N0M0 | Malignant |
I6 | 134 | M | 67 | Lung | Adenocarcinoma | 3 | T2N0M0 | Malignant |
I7 | 135 | M | 67 | Lung | Adenocarcinoma | 3 | T2N0M0 | Malignant |
I8 | 136 | M | 72 | Lung | Adenocarcinoma | 3 | T2N2M0 | Malignant |
I9 | 137 | M | 72 | Lung | Adenocarcinoma | 3 | T2N2M0 | Malignant |
I10 | 138 | M | 72 | Lung | Adenocarcinoma | 3 | T2N2M0 | Malignant |
I11 | 139 | F | 43 | Lung | Adenocarcinoma | 3 | T2N1M0 | Malignant |
I12 | 140 | F | 43 | Lung | Adenocarcinoma | 2 | T2N1M0 | Malignant |
I13 | 141 | F | 43 | Lung | Adenocarcinoma | 2 | T2N1M0 | Malignant |
I14 | 142 | M | 66 | Lung | Adenocarcinoma | 3 | T2N2M0 | Malignant |
I15 | 143 | M | 66 | Lung | Adenocarcinoma (tumoral necrosis) | – | T2N2M0 | Malignant |
I16 | 144 | M | 66 | Lung | Adenocarcinoma | 3 | T2N2M0 | Malignant |
J1 | 145 | M | 62 | Lung | Large cell undifferentiated carcinoma | – | T2N0M0 | Malignant |
J2 | 146 | M | 62 | Lung | Large cell undifferentiated carcinoma | – | T2N0M0 | Malignant |
J3 | 147 | M | 62 | Lung | Large cell undifferentiated carcinoma | – | T2N0M0 | Malignant |
J4 | 148 | M | 54 | Lung | Large cell undifferentiated carcinoma | – | T2N0M0 | Malignant |
J5 | 149 | M | 54 | Lung | Large cell undifferentiated carcinoma | – | T2N0M0 | Malignant |
J6 | 150 | M | 54 | Lung | Large cell undifferentiated carcinoma | – | T2N0M0 | Malignant |
J7 | 151 | M | 39 | Lung | Large cell undifferentiated carcinoma with neuroendocrine differentiation | – | T2NxM0 | Malignant |
J8 | 152 | M | 39 | Lung | Large cell undifferentiated carcinoma with neuroendocrine differentiation | – | T2NxM0 | Malignant |
J9 | 153 | M | 39 | Lung | Large cell undifferentiated carcinoma with neuroendocrine differentiation | – | T2NxM0 | Malignant |
J10 | 154 | M | 40 | Lung | Large cell undifferentiated carcinoma | – | T2NxM0 | Malignant |
J11 | 155 | M | 40 | Lung | Large cell undifferentiated carcinoma | – | T2NxM0 | Malignant |
J12 | 156 | M | 40 | Lung | Large cell undifferentiated carcinoma | – | T2NxM0 | Malignant |
J13 | 157 | M | 63 | Lung | Large cell undifferentiated carcinoma | – | T2NxM0 | Malignant |
J14 | 158 | M | 63 | Lung | Large cell undifferentiated carcinoma | – | T2NxM0 | Malignant |
J15 | 159 | M | 63 | Lung | Large cell undifferentiated carcinoma | – | T2NxM0 | Malignant |
J16 | 160 | M | 60 | Lung | Large cell undifferentiated carcinoma (sparse) | – | T2NxM0 | Malignant |
K1 | 161 | M | 60 | Lung | Large cell undifferentiated carcinoma | – | T2NxM0 | Malignant |
K2 | 162 | M | 60 | Lung | Large cell undifferentiated carcinoma | – | T2NxM0 | Malignant |
K3 | 163 | F | 45 | Lung | Large cell undifferentiated carcinoma | – | T2NxM0 | Malignant |
K4 | 164 | F | 45 | Lung | Large cell undifferentiated carcinoma | – | T2NxM0 | Malignant |
K5 | 165 | F | 45 | Lung | Large cell undifferentiated carcinoma | – | T2NxM0 | Malignant |
K6 | 166 | M | 64 | Lung | Large cell undifferentiated carcinoma | – | T1NxM0 | Malignant |
K7 | 167 | M | 64 | Lung | Large cell undifferentiated carcinoma | – | T1NxM0 | Malignant |
K8 | 168 | M | 64 | Lung | Large cell undifferentiated carcinoma | – | T1NxM0 | Malignant |
K9 | 169 | F | 65 | Lung | Large cell undifferentiated carcinoma | – | T2N1M0 | Malignant |
K10 | 170 | F | 65 | Lung | Large cell undifferentiated carcinoma | – | T2N1M0 | Malignant |
K11 | 171 | F | 65 | Lung | Large cell undifferentiated carcinoma | – | T2N1M0 | Malignant |
K12 | 172 | F | 69 | Lung | Large cell undifferentiated carcinoma | – | T2NxM0 | Malignant |
K13 | 173 | F | 69 | Lung | Large cell undifferentiated carcinoma | – | T2NxM0 | Malignant |
K14 | 174 | F | 69 | Lung | Large cell undifferentiated carcinoma (hyperplastic fibrous tissue) | – | T2NxM0 | Malignant |
K15 | 175 | M | 73 | Lung | Large cell undifferentiated carcinoma | – | T2NxM0 | Malignant |
K16 | 176 | M | 73 | Lung | Large cell undifferentiated carcinoma | – | T2NxM0 | Malignant |
L1 | 177 | M | 73 | Lung | Large cell undifferentiated carcinoma | – | T2NxM0 | Malignant |
L2 | 178 | F | 64 | Lung | Large cell undifferentiated carcinoma | – | T2NxM0 | Malignant |
L3 | 179 | F | 64 | Lung | Large cell undifferentiated carcinoma | – | T2NxM0 | Malignant |
L4 | 180 | F | 64 | Lung | Large cell undifferentiated carcinoma | – | T2NxM0 | Malignant |
L5 | 181 | M | 55 | Lung | Normal lung tissue | – | – | Normal |
L6 | 182 | M | 55 | Lung | Normal lung tissue | – | – | Normal |
L7 | 183 | M | 55 | Lung | Normal lung tissue | – | – | Normal |
L8 | 184 | M | 49 | Lung | Normal lung tissue with sparse giant cell | – | – | Normal |
L9 | 185 | M | 49 | Lung | Normal lung tissue with sparse giant cell | – | – | Normal |
L10 | 186 | M | 49 | Lung | Normal lung tissue with sparse giant cell | – | – | Normal |
L11 | 187 | F | 38 | Lung | Normal lung tissue | – | – | Normal |
L12 | 188 | F | 38 | Lung | Normal lung tissue | – | – | Normal |
L13 | 189 | F | 38 | Lung | Normal lung tissue | – | – | Normal |
L14 | 190 | M | 50 | Lung | Normal lung tissue | – | – | Normal |
L15 | 191 | M | 50 | Lung | Normal lung tissue | – | – | Normal |
L16 | 192 | M | 50 | Lung | Normal lung tissue | – | – | Normal |
M1 | 193 | F | 14 | Lung | Normal lung tissue with congestion | – | – | Normal |
M2 | 194 | F | 14 | Lung | Normal lung tissue with congestion | – | – | Normal |
M3 | 195 | F | 14 | Lung | Normal lung tissue with congestion | – | – | Normal |
M4 | 196 | M | 40 | Lung | Normal lung tissue | – | – | Normal |
M5 | 197 | M | 40 | Lung | Normal lung tissue | – | – | Normal |
M6 | 198 | M | 40 | Lung | Normal lung tissue | – | – | Normal |
M7 | 199 | M | 35 | Lung | Normal lung tissue | – | – | Normal |
M8 | 200 | M | 35 | Lung | Normal lung tissue | – | – | Normal |
M9 | 201 | M | 35 | Lung | Normal lung tissue | – | – | Normal |
M10 | 202 | M | 42 | Lung | Normal lung tissue | – | – | Normal |
M11 | 203 | M | 42 | Lung | Normal lung tissue | – | – | Normal |
M12 | 204 | M | 42 | Lung | Normal lung tissue | – | – | Normal |
M13 | 205 | M | 48 | Lung | Normal lung tissue | – | – | Normal |
M14 | 206 | M | 48 | Lung | Normal lung tissue | – | – | Normal |
M15 | 207 | M | 48 | Lung | Normal lung tissue | – | – | Normal |
M16 | 208 | M | 52 | Skin | Malignant melanoma | – | – | Malignant |
*For precise diagnosis, refer to pathology description.
追加しました。
ヒト組織アレイのFAQ
追加しました。
製品情報は掲載時点のものですが、価格表内の価格については随時最新のものに更新されます。お問い合わせいただくタイミングにより製品情報・価格などは変更されている場合があります。
表示価格に、消費税等は含まれていません。一部価格が予告なく変更される場合がありますので、あらかじめご了承下さい。